Literature DB >> 18700874

Epitope mapping of mAbs to denatured human testicular ACE (CD143).

I V Balyasnikova1, R Metzger, F E Franke, N Conrad, H Towbin, D E Schwartz, E D Sturrock, S M Danilov.   

Abstract

Angiotensin I-converting enzyme (ACE; CD143) has two homologous enzymatically active domains (N and C) and plays a crucial role in blood pressure regulation and vascular remodeling. A wide spectrum of monoclonal antibodies (mAbs) to different epitopes on the N and C domains of human ACE have been used to study different aspects of ACE biology. In this study, we characterized a set of nine mAbs, developed against the C domain of human ACE, which recognize the denatured forms of ACE and thus are suitable for the detection and quantification of somatic ACE (sACE) and testicular ACE (tACE) using Western blotting and immunohistochemistry on paraffin-embedded human tissues. The epitopes for these mAbs were defined using species cross-reactivity, phage display library screening, Western blotting and ACE mutagenesis. Most of the mAbs recognized common/overlapping region(s) on both somatic and testicular forms of human ACE, whereas mAb 4E10 was relatively specific for the testicular isoform and mAb 5B9 mainly recognized the glycan attached to Asn 731. This set of mAbs is useful for identifying even subtle changes in human ACE conformation because of denaturation. These mAbs are also sensitive tools for the detection of human sACE and tACE in biological fluids and tissues using proteomic approaches. Their high reactivity in paraffin-embedded tissues provides opportunities to study changes in the pattern of ACE expression and glycosylation (particularly with mAb 5B9) in different tissues and cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18700874     DOI: 10.1111/j.1399-0039.2008.01112.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain.

Authors:  Sergei M Danilov; Sergey Kalinin; Zhenlong Chen; Elena I Vinokour; Andrew B Nesterovitch; David E Schwartz; Olivier Gribouval; Marie-Claire Gubler; Richard D Minshall
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

2.  Conformational changes of blood ACE in chronic uremia.

Authors:  Maxim N Petrov; Valery Y Shilo; Alexandr V Tarasov; David E Schwartz; Joe G N Garcia; Olga A Kost; Sergei M Danilov
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

3.  A novel splice-site mutation in angiotensin I-converting enzyme (ACE) gene, c.3691+1G>A (IVS25+1G>A), causes a dramatic increase in circulating ACE through deletion of the transmembrane anchor.

Authors:  Alexandre Persu; Michel Lambert; Jaap Deinum; Marta Cossu; Nathalie de Visscher; Leonid Irenge; Jerôme Ambroise; Jean-Marc Minon; Andrew B Nesterovitch; Alexander Churbanov; Isolda A Popova; Sergei M Danilov; A H Jan Danser; Jean-Luc Gala
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

4.  Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling.

Authors:  Nicola E Clarke; Martin J Fisher; Karen E Porter; Daniel W Lambert; Anthony J Turner
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

5.  An angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE shedding.

Authors:  Sergei M Danilov; Kerry Gordon; Andrew B Nesterovitch; Heinrich Lünsdorf; Zhenlong Chen; Maricela Castellon; Isolda A Popova; Sergey Kalinin; Emma Mendonca; Pavel A Petukhov; David E Schwartz; Richard D Minshall; Edward D Sturrock
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

6.  Epitope mapping of novel monoclonal antibodies to human angiotensin I-converting enzyme.

Authors:  Isolda A Popova; Lizelle Lubbe; Pavel A Petukhov; Gavriil F Kalantarov; Ilya N Trakht; Elena R Chernykh; Olga Y Leplina; Alex V Lyubimov; Joe G N Garcia; Steven M Dudek; Edward D Sturrock; Sergei M Danilov
Journal:  Protein Sci       Date:  2021-05-11       Impact factor: 6.993

7.  A novel angiotensin I-converting enzyme mutation (S333W) impairs N-domain enzymatic cleavage of the anti-fibrotic peptide, AcSDKP.

Authors:  Sergei M Danilov; Michael S Wade; Sylva L Schwager; Ross G Douglas; Andrew B Nesterovitch; Isolda A Popova; Kyle D Hogarth; Nakul Bhardwaj; David E Schwartz; Edward D Sturrock; Joe G N Garcia
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

8.  Lysozyme and bilirubin bind to ACE and regulate its conformation and shedding.

Authors:  Sergei M Danilov; Heinrich Lünsdorf; Henry T Akinbi; Andrew B Nesterovitch; Yuliya Epshtein; Eleftheria Letsiou; Olga V Kryukova; Tobias Piegeler; Elena Z Golukhova; David E Schwartz; Randal O Dull; Richard D Minshall; Olga A Kost; Joe G N Garcia
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

9.  Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE.

Authors:  Andrew B Nesterovitch; Kyle D Hogarth; Vyacheslav A Adarichev; Elena I Vinokour; David E Schwartz; Julian Solway; Sergei M Danilov
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.